Cannabis RIV Capital Sets Date for Financial Results for the Fiscal Quarter and Nine-Month Transition Year Ended December 31, 2023 April 23, 2024
Cannabis Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain April 23, 2024
Cannabis Canopy Growth Announces CBI Conversion to Exchangeable Shares and Newly Constituted Board of Directors April 19, 2024
Cannabis Clearleaf Inc. Announces Launch of SampleDirect Platform alongside Cova, Greenline, a BLAZE® Company, and TechPOS April 18, 2024
Cannabis Mary Jones Named High Spirits Awards Best Cannabis Soda for Second Consecutive Year April 18, 2024
Cannabis Introducing Fable: Award-Winning THC-Infused Botanical Cocktails Launch Nationwide April 18, 2024